Multi-omics insights for deciphering prognosis-related T cell subsets in hepatocellular carcinoma.

Clinically, higher apCAF signature scores were associated with poorer prognosis in the ICGC and CHCC cohorts (Figure S9D,E ), whereas this association did not reach statistical significance in TCGA (Figure 7H ), and apCAF scores were not significantly associated with response to T+A therapy (Figure S9F ).

also in 111,027 other papers